Cancer Treatment Reviews
Volume 36, Issue 2 , Pages 131-141, April 2010

The choice of the antigen in the dendritic cell-based vaccine therapy for prostate cancer

  • Lina Matera

      Affiliations

    • Corresponding Author InformationTel.: +39 011 6961813; fax: +39 011 6634146.

Laboratory of Tumor Immunology, Department of Internal Medicine, University of Turin, Turin, Italy

Received 13 June 2009; received in revised form 29 October 2009; accepted 3 November 2009. published online 02 December 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0305-7372(09)00163-7

doi:10.1016/j.ctrv.2009.11.002

Cancer Treatment Reviews
Volume 36, Issue 2 , Pages 131-141, April 2010

Article Tools

* Image Usage & Resolution